搜索临床试验以:SB-121
总计3272个结果
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)撤销原发性骨髓纤维化 | 真性红细胞增多症,红细胞增多症后骨髓纤维化阶段 | 原发性血小板增多症中的骨髓纤维化转化美国
-
Stealth BioTherapeutics Inc.ICON Clinical Research完全的
-
TetraLogic PharmaceuticalsPPD; The Leukemia and Lymphoma Society; Veristat, Inc.; Therapeutics, Inc.完全的
-
Bausch Health Americas, Inc.完全的
-
University of Wisconsin, MadisonNational Institute of Dental and Craniofacial Research (NIDCR); Cellectar Biosciences, Inc.主动,不招人
-
Leiden University Medical Center招聘中
-
Antengene (Hangzhou) Biologics Co., Ltd.招聘中
-
Children's Hospital Medical Center, CincinnatiNational Institutes of Health (NIH)招聘中
-
NovalGen Ltd.招聘中滤泡性淋巴瘤 | 套细胞淋巴瘤 | 弥漫性大 B 细胞淋巴瘤 | 非小细胞肺癌 (NSCLC) | 小淋巴细胞淋巴瘤 | 恶性黑色素瘤 | 慢性淋巴细胞白血病英国
-
The First Affiliated Hospital of Zhengzhou University尚未招聘可切除的食管鳞状细胞癌
-
CorrectSequence Therapeutics Co., LtdFirst Affiliated Hospital of Guangxi Medical University邀请报名
-
Tvardi Therapeutics, IncorporatedM.D. Anderson Cancer Center主动,不招人
-
Verve Therapeutics, Inc.主动,不招人
-
Aldagen终止
-
Ocera Therapeutics完全的
-
Bioray LaboratoriesInstitute of Hematology & Hospital of Blood Diseases, Chinese Academy of Medical Sciences...尚未招聘镰状细胞性贫血症
-
Alaunos Therapeutics未知
-
GlaxoSmithKline完全的
-
TaiwanJ Pharmaceuticals Co., Ltd终止
-
Therapex Co., Ltd尚未招聘癌,非小细胞肺癌 | EGFR 突变晚期非小细胞肺癌
-
Ankyra Therapeutics, Inc招聘中